| Curcumin's Biomedical Applications | Lifetime | 26 | TR 1 | 98.90 |
| Graphene and Nanomaterials Applications | Lifetime | 142 | TR 1 | 99.01 |
| Cancer-related molecular mechanisms research | Lifetime | 469 | TR 1 | 98.52 |
| Nanoparticle-Based Drug Delivery | Lifetime | 213 | TR 1 | 99.04 |
| MicroRNA in disease regulation | Lifetime | 986 | TR 1 | 97.32 |
| RNA Interference and Gene Delivery | Lifetime | 995 | TR 1 | 97.66 |
| Circular RNAs in diseases | Lifetime | 527 | TR 1 | 96.95 |
| Nanoplatforms for cancer theranostics | Lifetime | 801 | TR 1 | 97.45 |
| Nanoparticles: synthesis and applications | Lifetime | 563 | TR 2 | 96.82 |
| Nanoparticle-Based Drug Delivery | 2021-2025 | 6 | TR 1 | 99.71 |
| Cancer-related molecular mechanisms research | 2021-2025 | 45 | TR 1 | 99.56 |
| Curcumin's Biomedical Applications | 2021-2025 | 3 | TR 1 | 99.22 |
| Graphene and Nanomaterials Applications | 2021-2025 | 21 | TR 1 | 99.31 |
| RNA Interference and Gene Delivery | 2021-2025 | 55 | TR 1 | 98.67 |
| MicroRNA in disease regulation | 2021-2025 | 89 | TR 1 | 98.51 |
| Nanoplatforms for cancer theranostics | 2021-2025 | 161 | TR 1 | 98.80 |
| Electrospun Nanofibers in Biomedical Applications | 2021-2025 | 120 | TR 1 | 97.96 |
| Circular RNAs in diseases | 2021-2025 | 77 | TR 1 | 97.93 |
| MXene and MAX Phase Materials | 2021-2025 | 290 | TR 2 | 96.96 |
| Advanced Drug Delivery Systems | 2021-2025 | 114 | TR 1 | 95.25 |
| 3D Printing in Biomedical Research | 2021-2025 | 297 | TR 3 | 94.85 |
| Wound Healing and Treatments | 2021-2025 | 388 | TR 3 | 92.49 |
| Nanoparticles: synthesis and applications | 2021-2025 | 479 | TR 11 | 93.23 |
| Autophagy in Disease and Therapy | 2021-2025 | 365 | TR 3 | 90.45 |
| Advancements in Transdermal Drug Delivery | 2021-2025 | 232 | TR 4 | 91.46 |
| Cancer Cells and Metastasis | 2021-2025 | 630 | TR 1 | 87.17 |
| Cancer Research and Treatments | 2021-2025 | 554 | TR 1 | 83.64 |
| Hydrogels: synthesis, properties, applications | 2021-2025 | 824 | TR 18 | 78.54 |
| Chemotherapy-induced cardiotoxicity and mitigation | 2021-2025 | 637 | TR 12 | 74.79 |
| Sirtuins and Resveratrol in Medicine | 2021-2025 | 463 | TR 4 | 67.80 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 957 | TR 1 | 66.49 |
| FOXO transcription factor regulation | 2021-2025 | 247 | TR 5 | 54.00 |
| Chemotherapy-induced organ toxicity mitigation | 2021-2025 | 534 | TR 82 | 49.39 |
